{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:22:43Z","timestamp":1782602563945,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T00:00:00Z","timestamp":1501804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014421","name":"EA Pharma Co., Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014421","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00535-017-1376-4","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T06:45:57Z","timestamp":1501829157000},"page":"494-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Complete mucosal healing of distal lesions induced by twice-daily budesonide 2-mg foam promoted clinical remission of mild-to-moderate ulcerative colitis with distal active inflammation: double-blind, randomized study"],"prefix":"10.1007","volume":"53","author":[{"given":"Makoto","family":"Naganuma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Tada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyonori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihito","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Hibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"key":"1376_CR1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/00365529609004876","volume":"31","author":"E Langholz","year":"1996","unstructured":"Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol. 1996;31:260\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"1376_CR2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00042737-199606000-00011","volume":"8","author":"RC Ayres","year":"1996","unstructured":"Ayres RC, Gillen CD, Walmsley RS, et al. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gastroenterol Hpatol. 1996;8:555\u20138.","journal-title":"Eur J Gastroenterol Hpatol"},{"key":"1376_CR3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/01.MIB.0000225339.91484.fc","volume":"12","author":"M Henriksen","year":"2006","unstructured":"Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowl Dis. 2006;12:543\u201350.","journal-title":"Inflamm Bowl Dis"},{"key":"1376_CR4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.giec.2014.03.005","volume":"24","author":"A Walsh","year":"2014","unstructured":"Walsh A, Palmer R, Travis S. Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity. Gastrointest Endosc Clin N Am. 2014;24:367\u201378.","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"1376_CR5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.dld.2013.06.010","volume":"45","author":"S Mazzuoli","year":"2013","unstructured":"Mazzuoli S, Guglielmi FW, Antonelli E, et al. Definition and evaluation of mucosal healing in clinical practice. Dig Liver Dis. 2013;45:969\u201377.","journal-title":"Dig Liver Dis"},{"key":"1376_CR6","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1053\/j.gastro.2011.06.054","volume":"141","author":"JF Colombel","year":"2011","unstructured":"Colombel JF, Rutgeerts P, Reinisch W, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141:1194\u2013201.","journal-title":"Gastroenterology"},{"key":"1376_CR7","doi-asserted-by":"crossref","first-page":"18367","DOI":"10.3748\/wjg.v20.i48.18367","volume":"20","author":"A Nakarai","year":"2014","unstructured":"Nakarai A, Kato J, Hiraoka S, et al. Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count. World J Gastroenterol. 2014;20:18367\u201374.","journal-title":"World J Gastroenterol"},{"key":"1376_CR8","doi-asserted-by":"crossref","first-page":"192794","DOI":"10.1155\/2013\/192794","volume":"2013","author":"K Yokoyama","year":"2013","unstructured":"Yokoyama K, Kobayashi K, Mukae M, et al. Clinical study of the relation between mucosal healing and long-term outcomes in ulcerative colitis. Gastroenterol Res Pract. 2013;2013:192794.","journal-title":"Gastroenterol Res Pract"},{"key":"1376_CR9","first-page":"60","volume":"2011","author":"M Watanabe","year":"2010","unstructured":"Watanabe M, Treatment Guideline for Ulcerative Colitis (revised in fiscal year 2010). Health and labour sciences research grants from the Japanese Ministry of Health, Labour and Welfare for research on measures for intractable diseases (inflammatory bowel disease). Integrated Shared Res Rep (2010). 2010;2011:60\u20133 (in Japanese).","journal-title":"Integrated Shared Res Rep (2010)"},{"key":"1376_CR10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.crohns.2012.09.002","volume":"6","author":"A Dignass","year":"2012","unstructured":"Dignass A, Lindsay JO, Sturm A, et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis. 2012;6:991\u20131030.","journal-title":"J Crohns Colitis"},{"key":"1376_CR11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1155\/1990\/708916","volume":"4","author":"R Brattsand","year":"1990","unstructured":"Brattsand R. Overview of newer glucocorticosteroid preparations for inflammatory bowel disease. Can J Gastroenterol. 1990;4:407\u201314.","journal-title":"Can J Gastroenterol"},{"key":"1376_CR12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0090-9556(25)06497-9","volume":"23","author":"G J\u00f6nsson","year":"1995","unstructured":"J\u00f6nsson G, Astr\u00f6m A, Andersson P. Budesonide is metabolized by cytochrome P450 3A (CYP3A) enzymes in human liver. Drug Metab Dispos. 1995;23:137\u201342.","journal-title":"Drug Metab Dispos"},{"key":"1376_CR13","first-page":"86","volume":"122","author":"A Ryrfeldt","year":"1982","unstructured":"Ryrfeldt A, Andersson P, Edsb\u00e4cker S, et al. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid. Eur J Respir Dis Suppl. 1982;122:86\u201395.","journal-title":"Eur J Respir Dis Suppl"},{"key":"1376_CR14","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/ecco-jcc\/jjv208","volume":"10","author":"M Naganuma","year":"2016","unstructured":"Naganuma M, Aoyama N, Suzuki Y, et al. Twice-daily budesonide 2-mg foam induces complete mucosal healing in patients with distal ulcerative colitis. J Crohns Colitis. 2016;10:828\u201336.","journal-title":"J Crohns Colitis"},{"key":"1376_CR15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2036.2007.03361.x","volume":"26","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn WJ, Kamm MA, Lichtenstein GR, et al. MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double blind, placebo controlled trails. Aliment Pharmacol Ther. 2007;26:205\u201315.","journal-title":"Aliment Pharmacol Ther"},{"key":"1376_CR16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2036.2005.02571.x","volume":"22","author":"M Brunner","year":"2005","unstructured":"Brunner M, Vogelsang H, Greinwald R, et al. Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis. Aliment Pharmacol Ther. 2005;22:463\u201370.","journal-title":"Aliment Pharmacol Ther"},{"key":"1376_CR17","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/apt.12362","volume":"38","author":"M Watanabe","year":"2013","unstructured":"Watanabe M, Nishino H, Sameshima Y, et al. Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation\u2014a placebo-controlled study. Aliment Pharmacol Ther. 2013;38:264\u201373.","journal-title":"Aliment Pharmacol Ther"},{"key":"1376_CR18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2036.1994.tb00340.x","volume":"8","author":"R L\u00f6fberg","year":"1994","unstructured":"L\u00f6fberg R, Ostergaard Thomsen O, Langholz E, et al. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis. Aliment Pharmacol Ther. 1994;8:623\u20139.","journal-title":"Aliment Pharmacol Ther"},{"key":"1376_CR19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2036.1995.tb00421.x","volume":"9","author":"M L\u00e9mann","year":"1995","unstructured":"L\u00e9mann M, Galian A, Rutgeerts P, et al. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment Pharmacol Ther. 1995;9:557\u201362.","journal-title":"Aliment Pharmacol Ther"},{"issue":"303\u201312","key":"1376_CR20","first-page":"21","volume":"23","author":"V Gross","year":"2006","unstructured":"Gross V, Bar-Meir S, Lavy A, et al. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis Aliment Pharmacol Ther. 2006;23(303\u201312):21.","journal-title":"Aliment Pharmacol Ther"},{"key":"1376_CR21","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/MIB.0000000000000860","volume":"22","author":"BP Bosworth","year":"2016","unstructured":"Bosworth BP, Sandborn WJ, Rubin DT, et al. Baseline oral 5-ASA use and efficacy and safety of budesonide foam in patients with ulcerative proctitis and ulcerative proctosigmoiditis: analysis of 2 phase 3 studies. Inflamm Bowel Dis. 2016;22:1881\u20136.","journal-title":"Inflamm Bowel Dis"},{"key":"1376_CR22","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2015.01.037","volume":"148","author":"WJ Sandborn","year":"2015","unstructured":"Sandborn WJ, Bosworth B, Zakko S, et al. Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis. Gastroenterology. 2015;148:740\u201350.","journal-title":"Gastroenterology"},{"key":"1376_CR23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1365-2036.2011.04800.x","volume":"34","author":"WJ Sandborn","year":"2011","unstructured":"Sandborn WJ, Hanauer S, Lichtenstein GR, et al. Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis\u2014additional results from two controlled studies. Aliment Pharmacol Ther. 2011;34:747\u201356.","journal-title":"Aliment Pharmacol Ther"},{"key":"1376_CR24","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.crohns.2014.05.005","volume":"8","author":"K Kobayashi","year":"2014","unstructured":"Kobayashi K, Hirai F, Naganuma M, et al. A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings. J Crohns Colitis. 2014;8:1444\u201353.","journal-title":"J Crohns Colitis"},{"key":"1376_CR25","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/ecco-jcc\/jjw104","volume":"10","author":"M Arai","year":"2016","unstructured":"Arai M, Naganuma M, Sugimoto S, et al. The ulcerative colitis endoscopic index of severity is useful to predict medium- to long-term prognosis in ulcerative colitis patients with clinical remission. J Crohns Colitis. 2016;10:1303\u20139.","journal-title":"J Crohns Colitis"},{"key":"1376_CR26","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1007\/s10620-015-3868-5","volume":"60","author":"DT Rubin","year":"2015","unstructured":"Rubin DT, Sandborn WJ, Bosworth B, et al. Budesonide foam has a favorable safety profile for inducing remission in mild-to-moderate ulcerative proctitis or proctosigmoiditis. Dig Dis Sci. 2015;60:3408\u201317.","journal-title":"Dig Dis Sci"}],"updated-by":[{"DOI":"10.1007\/s00535-017-1399-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T00:00:00Z","timestamp":1507852800000}}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00535-017-1376-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1376-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-017-1376-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T20:29:12Z","timestamp":1750796952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00535-017-1376-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["1376"],"URL":"https:\/\/doi.org\/10.1007\/s00535-017-1376-4","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,4]]}}}